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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x Tested and recĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AS  Automated Screening 
BT  Bagolini Test 
CT  Cover Test 
CV  Colour Vision 
EI  Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test  
NICU  Neonatal-intensive care unit 
PCT  Prism Cover Test 
PM  Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
Ret  Retinoscopy 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
VA  Visual Acuity  
WHO  World Health Organisation  
WT  Worth Test 
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3 Population and Healthcare Overview 
The population of Malta is 465,292 (World Bank, 2018a) and birth rate is estimated at 10.2 
births/1,000 population in 2016 (World Bank, 2018b). The change in population and birth 
rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Malta has a reported population density of 1,454 people per square kilometre in 2017 and 
this has risen from 1,016 people per square kilometre in 1961 (World Bank, 2018c). In terms 
of healthcare facilities, the total density of hospitals in 2013 was 0.93 per 100,000 population 
(WHO, 2016a). Infant mortality in 2017 is estimated at 2.9 deaths/1,000 live births in total 
(World Bank, 2018d). 
The average life expectancy in Malta is estimated at 82.5 years (World Bank, 2018e), with a 
death rate of 5.6 deaths/1,000 population in 2016 (World Bank, 2018f). Malta has a gross 
national income per capita (PPP int. $, 2013) of $28,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $3,072 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 9.8% (WHO, 2016b). 
 
 
 
 
 
 
 
 
Summary Vision Screening Data: Malta                                                             
8 
 
Figure 1: Change in the Total Population and Birth Rate in Malta between 1960 and 2017 
 
Source: Information sourced from World Bank (2018)  
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4 Vision Screening Commissioning and Guidance 
In Malta, vision screening is organised nationally, with no differences between regions. Vision 
screening is funded by the state and is embedded into a general preventative child healthcare 
screening system. The content of the vision screening programme is decided upon by 
orthoptists. The vision screening programme commenced nationally in 1989 and has been 
changed since its implementation. Specifically, in 1992 nurses were trained to perform all 
vision screening tests. In 2014, the screening age of school children was changed from 7 years 
to 5 years. Cover test and ocular motility have also been added, but the date of this change is 
unknown. Review of the vision screening programme is funded by the Department of Health 
and take place through learning sessions and conducted by the principal general practitioner 
(GP) in charge of the screening programme. The guidelines were last revised five years ago. 
Vision screening in Malta is conducted by nurses and GPs, of which there are approximately 
10 per million population. Ophthalmologists and paediatricians screen babies in neonatal 
paediatric intensive care unit only. No other general healthcare professionals have been 
identified that do not screen, but could do so with additional training. There is specific in-
service training in vision screening which lasts between 3 to 4 hours, but this is not accredited 
or certified. School nurses receive training periodically by the head of orthoptics. This training 
consists of both theory and practical sessions. 
There are no methods for quality monitoring imposed by the government and no research 
has been conducted concerning the vision screening programme in Malta.  
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5 Screening programme  
In Malta, the target conditions screened for are retinopathy of prematurity (ROP), congenital 
eye disorders and reduced visual acuity. The health care professionals delivering vision 
screening, venue for screening and tests used vary depending on the age of the child as shown 
in Tables 1, 2 and 3 respectively. Specific details of the screening offered within each age 
group are described more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies are screened by an ophthalmologist at 1 month of age in a hospital, or at an 
out-patient clinic if they have been discharged. The tests conducted at this age include eye 
inspection and retinal examination.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by a paediatrician in a child 
healthcare centre. The tests conducted at this age include eye inspection, fixation, red reflex 
testing and eye motility. These tests are performed at the post-natal visit at 6 weeks. Babies 
are referred after one abnormal test.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened by a nurse or a GP in a child healthcare centre. 
This is conducted at 2 months, 8 months and 18 months of age. The tests conducted at this 
age include eye inspection, fixation, red reflex testing, eye motility, Hirschberg test, retinal 
examination, pursuit movements, cover test and alternating cover test. Infants are referred 
after one abnormal or two inconclusive tests. 
5.4 Vision screening - 36 months to 7 years 
Between 36 months and 7 years of age children are screened three times by either a GP or a 
nurse in schools at 3 years, 5 years and 7 years of age. The tests conducted are fixation, eye 
motility, pursuit movements, cover test, alternating cover test, stereopsis (Lang Stereotest), 
colour vision and visual acuity measurement. Children are referred after one abnormal or two 
inconclusive tests. The optotypes used are Snellen charts and Sheridan-Gardiner single test 
cards. At 3 years the single-optotype letters are used.  The referral criteria are:  
Ɣ At 3 years of age: Vision less than 6/9 (0.67 decimal, 0.2 logMAR), suspected or 
manifest strabismus, ocular motility problem or failure of Lang test. 
Ɣ At 7 years of age: Vision less than 6/6 Snellen (1.0 decimal, 0.00 logMAR) in one or 
both eyes, failed stereotest, or manifest strabismus  
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist Nurse GP 
Preterm babies  × 9 × × 
0 to 3 months  9 × × × 
3 to 36 months  × × 9 9 
3 to 7 years  × × 9 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
EI RE Fix RR EM Hir PM CT ACT SV CV VA 
Preterm babies  9 9 × × × × × × × × × × 
0 to 3 months  9 × 9 9 9 × × × × × × × 
3 to 36 months  9 9 9 9 9 9 9 9 9 × × × 
3 to 7 years  × × 9 × 9 × 9 9 9 9 9 9 
 
Key: EI: Eye inspection; RE: Retinal Examination; Fix: Fixation; RR: Red reflex testing; EM: Eye motility; Hir: Hirschberg; PM: Pursuit movements; 
CT: Cover test; ACT: Alternating cover test; SV: Stereopsis; CV: Colour vision; VA: Visual acuity   
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Child Healthcare Centre School 
Preterm babies  9 × × 
0 to 3 months  × 9 × 
3 to 36 months  × 9 × 
3 to 7 years  × × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. No 
automated screening is conducted in Malta.  
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7 Provision for Visually Impaired  
In Malta, there is one school for blind or severely visually impaired children; there are 
approximately 50 spaces available for children to attend. The costs per child for these schools 
is t not known. There is special support for visually impaired children who attend regular 
mainstream primary school, including financial support from social services and non-
government organisations as well as visits by a specialised teacher.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
There is only data concerning a rough estimation based on professional opinion, of the 
prevalence of strabismus at 2 years of age, which is 2.5-3.0%.  
8.2 Coverage 
Children are invited for vision screening by their school health service; approximately 3,000 
children per year. It is estimated that greater than 75% of children are invited for screening 
and that the attendance rate is greater than 90%.  
8.3 Screening evaluation 
No data available.  
8.4 Treatment success 
Optometrists and orthoptists are the only professionals that prescribe glasses for children 
under the age of 7 years in Malta. Other treatment options available include patching and 
cataract surgery (if appropriate). All eligible children are offered treatment. There is no other 
data available.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs, per year, for vision screening professionals is estimated at between 23,000-
30,000 Euros. The salary costs per hour for vision screening are estimated at between 12-15 
Euros per hour. It is not known how much it costs to train general preventative child 
healthcare screening professionals, between leaving secondary education and qualification. 
The total vision screening costs per year, or per child per year, are not known.  
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients, with refractive amblyopia and 
strabismic amblyopia (including follow up) are 200 Euros for glasses, 4 visits in the first year, 
2 visits the next year and then a visit every year after 8 years of age (25 Euros per visit). There 
is not further data available.  
9.3 Cost of Treatment for strabismus  
 No data available.  
9.4 Cost of treatment for cataract 
No data available.  
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